mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Recombinant technology has been around for nearly three quarters of a century and has revolutionized protein therapy. However, the cost of developing recombinant therapeutic proteins...